ConductScience.org, home

Paper39807474

Effects of therapy in experimental models of Peyronie's disease: a scoping review.

Wiborg MH and 3 others. Sex Med, 2024. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Effects of therapy in experimental models of Peyronie's disease: a scoping review. Papers, record 39807474. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39807474

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of therapy in experimental models of Peyronie's disease: a scoping review.
PubMed
Journal
Sex Med
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-02-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wiborg MHMajken Højruphttps://orcid.org/0000-0002-4908-6517
2Krøijer RRasmus
3Laursen BSBirgitte Schantz
4Lund LLars

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125156514The anti-inflammatory and antifibrosis effects of anthocyanin extracted from black soybean on a Peyronie disease rat model.Urology2014https://conductscience.org/library/papers/25156514PubMed
234559023Laboratory animals search filter for different literature databases: PubMed, Embase, Web of Science and PsycINFO.Lab Anim2022https://conductscience.org/library/papers/34559023PubMed
316469038Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease.BJU Int2006https://conductscience.org/library/papers/16469038PubMed
435908015Intratunical injection of rat-derived bone marrow mesenchymal stem cells prevents fibrosis and is associated with increased Smad7 expression in a rat model of Peyronie's disease.Stem Cell Res Ther2022https://conductscience.org/library/papers/35908015PubMed
525847891Smoking, diabetes, blood hypertension: possible etiologic role for Peyronie's disease? Analysis in 279 patients with a control group in Sicily.Arch Ital Urol Androl2015https://conductscience.org/library/papers/25847891PubMed
61486392The treatment of Peyronie's disease with tamoxifen.Br J Urol1992https://conductscience.org/library/papers/1486392PubMed
737926870The Effect of Pirfenidone on Peyronie Plaques and Erectile Function in a Peyronie's Rat Model.J Coll Physicians Surg Pak2023https://conductscience.org/library/papers/37926870PubMed
830387224Prevalence of penile curvature: a population-based cross-sectional study in metropolitan and rural cities in Australia.BJU Int2018https://conductscience.org/library/papers/30387224PubMed
933038124Updated methodological guidance for the conduct of scoping reviews.JBI Evid Synth2020https://conductscience.org/library/papers/33038124PubMed
109302128Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression.J Urol1997https://conductscience.org/library/papers/9302128PubMed
1112454687Gene expression in Peyronie's disease.Int J Impot Res2002https://conductscience.org/library/papers/12454687PubMed
1221633367The association between Peyronie's and Dupuytren's disease.Int J Impot Res2011https://conductscience.org/library/papers/21633367PubMed
1337547872European Society of Sexual Medicine consensus statement on the use of animal models for studying Peyronie's disease.Sex Med2023https://conductscience.org/library/papers/37547872PubMed
1438672406Uncovering Novel Protein Partners of Inducible Nitric Oxide Synthase in Human Testis.Biomolecules2024https://conductscience.org/library/papers/38672406PubMed
1530670839Therapeutic areas of Li-ESWT in sexual medicine other than erectile dysfunction.Int J Impot Res2019https://conductscience.org/library/papers/30670839PubMed
1637373277Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie's Disease.Int J Mol Sci2023https://conductscience.org/library/papers/37373277PubMed
1719267860Mechanisms of penile fibrosis.J Sex Med2009https://conductscience.org/library/papers/19267860PubMed
1831000815Anti-fibrotic effect of mycophenolate mofetil on Peyronie's disease experimentally induced with TGF-β.Int J Impot Res2020https://conductscience.org/library/papers/31000815PubMed
1910332485The effects of colchicine on a Peyronie's-like condition in an animal model.J Urol1999https://conductscience.org/library/papers/10332485PubMed
2010799245A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression.J Urol2000https://conductscience.org/library/papers/10799245PubMed

See all 70 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
39807474Effects of therapy in experimental models of Peyronie's disease: a scoping review.Sex Med2024https://conductscience.org/library/papers/39807474

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39807474

GET https://conductscience.org/api/papers/v1/39807474/references?page=2